|1.||Bracht, Adelar: 2 articles (03/2014 - 01/2013)|
|2.||Comar, Jurandir Fernando: 2 articles (03/2014 - 01/2013)|
|3.||de Oliveira, Andrea Luiza: 2 articles (03/2014 - 01/2013)|
|4.||Peralta, Rosane Marina: 2 articles (03/2014 - 01/2013)|
|5.||Rodgers, R J: 2 articles (11/2010 - 10/2003)|
|6.||Abbate-Daga, Giovanni: 2 articles (05/2009 - 07/2004)|
|7.||Fassino, Secondo: 2 articles (05/2009 - 07/2004)|
|8.||Halmi, Katherine A: 2 articles (01/2008 - 01/2003)|
|9.||Wideman, R F: 2 articles (01/2008 - 12/2006)|
|10.||Chapman, M E: 2 articles (01/2008 - 12/2006)|
|1.||Weight Loss (Weight Reduction)
03/01/1996 - "Recent studies have documented the safety and efficacy of certain appetite suppressants for assisting in long-term weight loss and maintenance of weight loss. "
11/02/1987 - "This study compared the effects of chronic administration of anorexigenic drugs on weight loss in mice. "
07/01/2015 - "D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell."
01/01/2013 - "The fruit extracts of Citrus aurantium (bitter orange) are traditionally used as weight-loss products and as appetite suppressants. "
04/01/2011 - "Appetite suppressants as adjuncts for weight loss."
01/01/2008 - "If appetite suppressants are to become a more important tool in obesity treatment, agents that do not lose efficacy when administered for extended periods of time must be identified."
10/01/1993 - "The apparent short-term efficacy of these appetite-suppressant drugs and the lack of severe adverse drug effects or addiction suggest that they may be useful in the treatment of obesity. "
01/01/1951 - "Obesity in diabetes: a study of therapy with anorexigenic drugs."
06/01/2014 - "Generally, anti-obesity medications are classified as appetite suppressants or fat absorption blockers. "
01/01/2013 - "Many drugs for the treatment of obesity, which mainly act through CNS as appetite suppressants, have failed during development or been removed from the market due to unacceptable adverse effects. "
|3.||Type 2 Diabetes Mellitus (MODY)
09/01/1997 - "Adjunct treatments comprise a few pharmacological approaches which may help to improve glycaemic control by correcting some abnormalities frequently associated with NIDDM, such as obesity (serotoninergic anorectic agents) and hyperlipidaemia (benfluorex). "
12/01/1992 - "Anorectic agents have been shown to improve insulin action in NIDDM, irrespective of weight reduction. "
02/01/1992 - "Anorectic agents have been shown to improve insulin action in NIDDM, irrespective of weight reduction. "
|4.||Bulimia (Binge Eating)
12/01/1986 - "We undertook a study to see if putative anorectic agents could attenuate binge eating episodes in bulimic patients. "
06/01/2003 - "All participants were women 15 to 18 years old: 58 anorectics (35 restricting, 23 binge eating/purging) and 59 matched healthy controls. "
03/01/2000 - "No significant differences were found between pure bulimics and binge eating-purging anorectics. "
06/01/2004 - "Restrictor anorectics are characterized by high Persistence (P) and a relatively higher SD, and bulimics by higher Novelty Seeking (NS) and the lowest SD, while binge/purging and purging anorectics share some traits with anorexia and some with bulimia. "
02/01/2002 - "For the time being, the combination of cognitive behavioural therapy and behavioural strategies for weight loss is the most effective procedure to reduce binge eating and to facilitate short-term weight loss; the addition of anti-depressive medication or appetite suppressants seems to give a moderate increase in weight loss. "
01/01/2003 - "To date, neither CNS stimulants nor anorectic agents have been effective in treating hyperphagia, in part because hyperphagia in Prader-Willi syndrome is attributed to decreased satiation as opposed to increased hunger. "
05/06/1985 - "Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and 2-DG-induced hyperphagia."
03/01/1977 - "Anorectic agents such as d-amphetamine and fenfluramine showed a remarkably higher effect in rats with hyperphagia after lesioning the ventromedial hypothalamus. "
01/01/1973 - "Hyperphagia in cats induced by injection of sodium pentobarbital into cerebral ventricles as a method for testing anorectics."
05/06/1985 - "It was found that anorectics that act through a serotoninergic mechanism, i.e., d- and d-l-fenfluramine, p-chloroamphetamine, quipazine and fluoxetine antagonize both insulin- and 2-DG-induced overeating, while anorectics acting through the dopaminergic system, i.e., d-amphetamine, diethylpropion, lisuride, bromocriptine and mazindol, antagonize the hyperphagia induced by 2-DG but not that induced by insulin. "
|5.||benfluorex (S 780)
|6.||neuropeptide Y5 receptor
|9.||Biogenic Amines (Biogenic Amine)
|1.||Drug Therapy (Chemotherapy)